Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

M1 macrophage subtypes activation and adipocyte dysfunction worsen during prolonged consumption of a fructose-rich diet.

Gambaro SE, Zubiría MG, Portales AE, Rey MA, Rumbo M, Giovambattista A.

J Nutr Biochem. 2018 Nov;61:173-182. doi: 10.1016/j.jnutbio.2018.08.004. Epub 2018 Aug 21.

PMID:
30245336
2.

Deleterious Metabolic Effects of High Fructose Intake: The Preventive Effect of Lactobacillus kefiri Administration.

Zubiría MG, Gambaro SE, Rey MA, Carasi P, Serradell MLÁ, Giovambattista A.

Nutrients. 2017 May 17;9(5). pii: E470. doi: 10.3390/nu9050470.

3.

Long-Term Fructose Intake Increases Adipogenic Potential: Evidence of Direct Effects of Fructose on Adipocyte Precursor Cells.

Zubiría MG, Alzamendi A, Moreno G, Rey MA, Spinedi E, Giovambattista A.

Nutrients. 2016 Apr 2;8(4):198. doi: 10.3390/nu8040198.

4.

Increased daylight availability reduces length of hospitalisation in depressive patients.

Canellas F, Mestre L, Belber M, Frontera G, Rey MA, Rial R.

Eur Arch Psychiatry Clin Neurosci. 2016 Apr;266(3):277-80. doi: 10.1007/s00406-015-0601-5. Epub 2015 May 23.

PMID:
26001740
5.

ALAT-2014 Chronic Obstructive Pulmonary Disease (COPD) Clinical Practice Guidelines: questions and answers.

Montes de Oca M, López Varela MV, Acuña A, Schiavi E, Rey MA, Jardim J, Casas A, Tokumoto A, Torres Duque CA, Ramírez-Venegas A, García G, Stirbulov R, Camelier A, Bergna M, Cohen M, Guzmán S, Sánchez E.

Arch Bronconeumol. 2015 Aug;51(8):403-16. doi: 10.1016/j.arbres.2014.11.017. Epub 2015 Jan 14. English, Spanish.

6.

Diagnostic accuracy of behavioral variant frontotemporal dementia consortium criteria (FTDC) in a clinicopathological cohort.

Balasa M, Gelpi E, Martín I, Antonell A, Rey MJ, Grau-Rivera O, Molinuevo JL, Sánchez-Valle R, Lladó A; Catalan collaborative Study Group for FTLD.

Neuropathol Appl Neurobiol. 2015 Dec;41(7):882-92. doi: 10.1111/nan.12194. Epub 2015 May 2.

PMID:
25381753
7.

The effect of valsartan versus non-RAAS treatment on autoregulation of cerebral blood flow.

Périard D, Rey MA, Casagrande D, Vesin JM, Carrera E, Hayoz D.

Cerebrovasc Dis. 2012;34(1):78-85. doi: 10.1159/000338777. Epub 2012 Jul 14.

PMID:
22814178
8.

In vivo evidence of cross-reactivity between cow's milk and soybean proteins in a mouse model of food allergy.

Smaldini P, Curciarello R, Candreva A, Rey MA, Fossati CA, Petruccelli S, Docena GH.

Int Arch Allergy Immunol. 2012;158(4):335-46. doi: 10.1159/000333562. Epub 2012 Apr 3.

PMID:
22472742
9.

[Treatment and prevention of venous thromboembolic disease: what's new?].

Rey MA, Bron C, Haesler E, Mazzolai L.

Rev Med Suisse. 2009 Feb 4;5(189):316-20. French.

PMID:
19271649
10.

Enhanced alternative splicing of the FLVCR1 gene in Diamond Blackfan anemia disrupts FLVCR1 expression and function that are critical for erythropoiesis.

Rey MA, Duffy SP, Brown JK, Kennedy JA, Dick JE, Dror Y, Tailor CS.

Haematologica. 2008 Nov;93(11):1617-26. doi: 10.3324/haematol.13359. Epub 2008 Sep 24.

11.
12.

Hypogammaglobulinaemia secondary to cow-milk allergy in children under 2 years of age.

Bezrodnik L, Raccio AC, Canil LM, Rey MA, Carabajal PC, Fossati CA, Docena GH.

Immunology. 2007 Sep;122(1):140-6. Epub 2007 May 11.

13.
14.
15.

Lymphoid interstitial pneumonitis and infection with human immunodeficiency virus type 2.

Couderc LJ, Brun-Vezinet F, Rey MA, Michard P, Clauvel JP.

Chest. 1991 May;99(5):1320. No abstract available.

PMID:
2019216
16.

Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers.

Rey MA, Laurent AG, McClure J, Krust B, Montagnier L, Hovanessian AG.

J Virol. 1990 Feb;64(2):922-6.

17.

Characterization of an HIV-2-related virus with a smaller sized extracellular envelope glycoprotein.

Rey MA, Krust B, Laurent AG, Guétard D, Montagnier L, Hovanessian AG.

Virology. 1989 Nov;173(1):258-67.

PMID:
2683362
18.

Cell surface expression of several species of human immunodeficiency virus type 1 major core protein.

Laurent AG, Krust B, Rey MA, Montagnier L, Hovanessian AG.

J Virol. 1989 Sep;63(9):4074-8.

19.

On the processing of HIV-2 envelope glycoproteins.

Rey MA, Hovanessian AG.

Res Virol. 1989 May-Jun;140(3):271-4. No abstract available.

PMID:
2756243
20.

Immunoglobulins and complement components in 37 patients infected by HIV-1 virus: comparison of general (systemic) and intrathecal immunity.

Reboul J, Schuller E, Pialoux G, Rey MA, Lebon P, Allinquant B, Brun-Vezinet F.

J Neurol Sci. 1989 Feb;89(2-3):243-52.

PMID:
2926452
21.
22.

Prenatal diagnosis of HIV infection: two attempts using fetal blood sampling.

Daffos F, Forestier F, Mandelbrot L, Pialoux G, Rey MA, Brun-Vezinet F.

J Acquir Immune Defic Syndr. 1989;2(2):205-7.

PMID:
2703959
23.

Prospective study of HIV I seropositive patients in hemodialysis centers.

Assogba U, Park RA, Rey MA, Barthelemy A, Rottembourg J, Gluckman JC.

Clin Nephrol. 1988 Jun;29(6):312-4.

PMID:
3396235
24.

Intrathecal immunity in 37 patients seropositive for anti-HIV-1 antibody.

Reboul J, Schuller E, Pialoux G, Rey MA, Lebon P, Brun-Vezinet F.

Ann N Y Acad Sci. 1988;540:619-23. No abstract available.

PMID:
3207291
25.

[HIV1 infections in dialysis centers. Prospective studies in 4 centers in Ile-de-France].

Assogba U, Rey MA, Ancelle RM, Rottembourg J, Gluckman JC.

Nephrologie. 1988;9(3):139-41. French.

PMID:
3194045
26.

[Retroviral infections by HIV-1, HIV-2 and AIDS-related complex in the Ivory Coast].

Ouattara A, Rey MA, Brun-Vésinet F, Kindbeiter K, de Thé G.

C R Acad Sci III. 1988;306(2):47-50. French.

PMID:
2894887
27.

[Trial of 3 months' prolonged treatment with cyclosporin in AIDS].

Leport C, Levacher M, Michon C, Rey MA, Rouveix B, Jelazko P.

Presse Med. 1987 Dec 12;16(42):2127-8. French. No abstract available.

PMID:
2963288
28.

Cholangitis in the acquired immunodeficiency syndrome: report of two cases and review of the literature.

Roulot D, Valla D, Brun-Vezinet F, Rey MA, Clavel F, Degott C, Guillan J, Verduron J, Rueff B, Benhamou JP.

Gut. 1987 Dec;28(12):1653-60. Review.

29.

Retrospective seroepidemiology of AIDS virus infection in Nairobi populations.

Piot P, Plummer FA, Rey MA, Ngugi EN, Rouzioux C, Ndinya-Achola JO, Veracauteren G, D'Costa LJ, Laga M, Nsanze H, et al.

J Infect Dis. 1987 Jun;155(6):1108-12.

PMID:
3471817
30.

Long incubation period for HIV-2 infection.

Ancelle R, Bletry O, Baglin AC, Brun-Vezinet F, Rey MA, Godeau P.

Lancet. 1987 Mar 21;1(8534):688-9. No abstract available.

PMID:
2882111
31.

HIV-2/LAV-2 in Portuguese man with AIDS (Paris, 1978) who had served in Angola in 1968-74.

Saimot AG, Coulaud JP, Mechali D, Matheron S, Dazza MC, Rey MA, Brun-Vezinet F, Leibowitch J.

Lancet. 1987 Mar 21;1(8534):688. No abstract available.

PMID:
2882109
32.

HIV-1 and HIV-2 double infection in French homosexual male with AIDS-related complex (Paris, 1985)

Rey MA, Girard PM, Harzic M, Madjar JJ, Brun-Vezinet F, Saimot AG.

Lancet. 1987 Feb 14;1(8529):388-9. No abstract available.

PMID:
2880194
33.

HIV-2 infection in two homosexual men in France.

Brücker G, Brun-Vezinet F, Rosenheim M, Rey MA, Katlama C, Gentilini M.

Lancet. 1987 Jan 24;1(8526):223. No abstract available.

PMID:
2880053
34.

Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients.

Brun-Vezinet F, Rey MA, Katlama C, Girard PM, Roulot D, Yeni P, Lenoble L, Clavel F, Alizon M, Gadelle S, et al.

Lancet. 1987 Jan 17;1(8525):128-32.

PMID:
2879971
35.

[Clinical and virological study of a case of infection with the HIV-LAV 2 virus].

Saimot AG, Girard PM, Brun-Vezinet F, Bartczak S, Rey MA, Coulaud JP.

Ann Med Interne (Paris). 1987;138(6):419-21. French.

PMID:
2893571
36.

Isolation of a new human retrovirus from West African patients with AIDS.

Clavel F, Guétard D, Brun-Vézinet F, Chamaret S, Rey MA, Santos-Ferreira MO, Laurent AG, Dauguet C, Katlama C, Rouzioux C, et al.

Science. 1986 Jul 18;233(4761):343-6.

PMID:
2425430
37.

[Absence of anti-LAV antibodies in connective tissue diseases].

Gioud Paquet M, Kahn MF, Rouzioux C, Brun-Vezinet F, Rey MA.

Presse Med. 1986 Apr 26;15(17):802. French. No abstract available.

PMID:
3012506
38.

Lack of evidence for human or simian T-lymphotropic viruses type III infection in pygmies.

Brun-Vezinet F, Jaeger G, Rouzioux C, Rey MA, Dazza MC, Chamaret S, Montagnier L, Charmot G.

Lancet. 1986 Apr 12;1(8485):854. No abstract available.

PMID:
2870333
39.

LAV/HTLV-III antibodies in connective tissue diseases.

Gioud-Paquet M, Kahn MF, Rouzioux C, Brun-Vezinet F, Rey MA.

Lancet. 1985 Sep 7;2(8454):554. No abstract available.

PMID:
2863569
40.

Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus).

Rey MA, Spire B, Dormont D, Barre-Sinoussi F, Montagnier L, Chermann JC.

Biochem Biophys Res Commun. 1984 May 31;121(1):126-33.

PMID:
6203528

Supplemental Content

Loading ...
Support Center